ARCHIVES

Bezwoda’s ’95 Phase II Study Entirely A Sham, Audit Finds.

This article is from The Cancer Letter archive.

Vol. 27 No. 17 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

The Philadelphia Story: How Surprise Filing by Abramson Spurred Penn to Follow Suit

March 16, 2012

Cooperative Group chairmen Cool, But High Priority Trials To Continue

January 18, 1991

Talking Back: FDA Faces Challenges Over Avastin & Prostate Cancer Prevention

January 21, 2011

Letter: Headline Criticized On Letter About Consortium

June 21, 1996

Appropriations 2013: Obama Proposes Flat Funding for NIH

February 17, 2012

Frozen Section Analysis Helps Avoid Second Surgery

September 30, 2005